All the news

People living with HIV do not have a higher risk of liver-related complications or death from liver disease after hepatitis C treatment with direct-acting antivirals, researchers from the French HEPAVIH cohort reported this ...

People with HIV who were cured of hepatitis C were less likely than HIV-negative people to develop hepatocellular carcinoma (HCC – liver cancer) in the three-and-a-half years after completing hepatitis C treatment, Spanish ...

Hepatitis C transmission during anal sex can take place without bleeding, trauma or sharing of injecting equipment and exposure to semen is likely to be enough for the virus to ...

The European Association for the Study of the Liver (EASL) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) have updated their guidance on chronic liver disease and COVID-19, issued in ...

Major gaps in hepatitis elimination efforts throughout the world threaten achievement of the World Health Organization (WHO) targets for achieving substantial reductions in new infections and deaths due to viral hepatitis by 2030, ...

Hepatitis elimination efforts are being severely affected by the COVID-19 pandemic in many settings, results of a 32-country survey by the World Hepatitis Alliance show. The survey of civil society hepatitis organisations and frontline ...

Pregnant women who test positive for hepatitis B infection and have a high level of hepatitis B virus (HBV) in the blood should receive preventive antiviral therapy with tenofovir from the 28th week ...

Hepatitis C infection doubles the risk of developing cancers of the oral cavity, upper throat and larynx, a meta-analysis of eight studies has shown and the study authors say that people with ...

Increases in liver enzymes are common in people with COVID-19 and occur more frequently in people with severe COVID-19, a meta-analysis of studies published in Hepatology International shows. Most liver enzyme elevations were ...

Sofosbuvir and daclatasvir, two antiviral drugs used to treat hepatitis C, were associated with faster recovery, shorter hospitalisation and improve survival among people with moderate or severe COVID-19, researchers reported this month at the ...